Lipolysis of emulsion models of triglyceride-rich lipoproteins is altered in male patients with abdominal aorta aneurysm

Brazilian Journal of Medical and Biological Research

Volumn 40, Issue 3, 2007, Pages 305-307

  Hosni, J J ^a   Vinagre, C G ^a   Mady, C ^a   Maranhao R C ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Faculdade de Ciências Farmacêuticas   (Brazil)

Author keywords

Abdominal aortic aneurysm; Chylomicrons; Emulsions; Lipoproteins

Indexed keywords

CARBON 14; CHOLESTEROL OLEATE; CHYLOMICRON; LIPID; TRIOLEIN; TRITIUM;

ABDOMINAL AORTA ANEURYSM; AGED; ARTICLE; CLINICAL ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; EMULSION; HUMAN; ISOTOPE LABELING; LIPID BLOOD LEVEL; LIPOLYSIS; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; PATHOGENESIS; RISK FACTOR; STATISTICAL SIGNIFICANCE;

EID: 33947149009     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2007000300004     Document Type: Article

References (12)

1. Reed D, Reed C, Stemmermann G, Hayashi T. Are aortic aneurysms caused by atherosclerosis? Circulation 1992; 85: 205-211.
2. Groot PH, van Stiphout WA, Krauss XH, Jansen H, van Tol A, van Ramshorst E, et al. Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb 1991; 11: 653-662.
3. Karpe F, Steiner G, Uffelman K, Olivecrona T, Hamsten A. Post-prandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis 1994; 106: 83-97.
4. Maranhao RC, Feres MC, Martins MT, Mesquita CH, Toffoletto O, Vinagre CG, et al. Plasma kinetics of a chylomicron-like emulsion in patients with coronary artery disease. Atherosclerosis 1996; 126: 15-25.
5. Weintraub MS, Grosskopf I, Rassin T, Miller H, Charach G, Rotmensch HH, et al. Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: case control study over three years. BMJ 1996; 312: 936-939.
6. Oliveira MR, Maranhao RC. Plasma kinetics of a chylomicron-like emulsion in normolipidemic obese women after a short-period weight loss by energy-restricted diet. Metabolism 2002; 51: 1097-1103.
7. American Diabetes Association. Standards of medical care in diabetes - 2006. Diabetes Care 2006; 29 (Suppl 1): S4-S42.
8. Simoni G, Gianotti A, Ardia A, Baiardi A, Galleano R, Civalleri D. Screening study of abdominal aortic aneurysm in a general population: lipid parameters. Cardiovasc Surg 1996; 4: 445-448.
9. Brady AR, Thompson SG, Fowkes FG, Greenhalgh RM, Powell JT. Abdominal aortic aneurysm expansion: risk factors and time intervals for surveillance. Circulation 2004; 110: 16-21.
10. Sposito AC, Lemos PA, Santos RD, Hueb W, Vinagre CG, Quintella E, et al. Impaired intravascular triglyceride lipolysis constitutes a marker of clinical outcome in patients with stable angina undergoing secondary prevention treatment: a long-term follow-up study. J Am Coll Cardiol 2004; 43: 2225-2232.
11. Hill MR, Clarke S, Rodgers K, Thornhill B, Peters JM, Gonzalez FJ, et al. Effect of peroxisome proliferator-activated receptor alpha activators on tumor necrosis factor expression in mice during endotoxemia. Infect Immun 1999; 67: 3488-3493.
12. Marx N, Sukhova GK, Collins T, Libby P, Plutzky J. PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells. Circulation 1999; 99: 3125-3131.